Challenge of Rechallenge: When to Resume Immunotherapy Following an Immune-Related Adverse Event
Erica C Nakajima, Evan J Lipson, Julie R Brahmer
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2019 October 20, 37 (30): 2714-2718
31461381
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
Full Text Links
Find Full Text Links for this Article
You are not logged in. Sign Up or Log In to join the discussion.